Pablo Juárez Archive — Page 1 of 1

Vanderbilt Kennedy Center Director Jeffrey Neul, MD, PhD; Administration on Disabilities Commissioner Rebecca Hines, PhD; VKC University Center for Excellence in Developmental Disabilities Co-Directors Pablo Juárez, MEd, BCBA, LBA; and Julie Lounds Taylor, PhD; and AoD Director Ophelia McLain, DHA, MPH, during a recent visit to the Vanderbilt Kennedy Center. (photo by Donn Jones)
September 10, 2026

Administration on Disabilities top leaders visit Vanderbilt Kennedy Center

The visit demonstrated the impact of the UCEDD model and the importance of strong, connected developmental disabilities networks.

January 12, 2026

Pablo Juárez named president-elect of the Association of University Centers on Disabilities

Juárez’s election to this role reflects his long-standing commitment to innovation in the field of intellectual and developmental disabilities.

October 25, 2024

VKC TRIAD celebrates 25 years of autism research, assessment, treatment and support with a special virtual event on Tuesday, Oct. 29

The special virtual event from 6 to 7:30 p.m. will feature TRIAD leaders past and present.

July 5, 2023

Julie Lounds Taylor and Pablo Juárez appointed new co-directors of the Vanderbilt Kennedy Center University Center for Excellence in Developmental Disabilities

The Vanderbilt Kennedy Center (VKC) has announced new leadership for its University Center for Excellence in Developmental Disabilities (UCEDD). Julie Lounds Taylor, PhD, and Pablo Juárez, MEd, BCBA, LBA, have succeeded Elise McMillan, JD, who retired June 30.

September 8, 2022

Juárez named director of behavior analysis

Pablo Juárez, MEd, BCBA, LBA, has been named director of behavior analysis within the Vanderbilt Kennedy Center and the Division of Developmental Medicine at Vanderbilt University Medical Center.

Boy looking through blinds
April 26, 2018

New report shows prevalence of autism rising in U.S.

The prevalence of U.S. children with autism spectrum disorder (ASD) is now 1 in 59, according to new estimates released Thursday by the Centers for Disease Control and Prevention (CDC), a significant increase from the 1 in 68 estimate in 2016.